ETFs with 100% Downside Protection: Should You Buy?
- Defined-outcome ETFs: Fast-growing segment of the ETF market allowing investors to cap upside returns while limiting losses.
- Calamos S&P 500 Structured Alternative Protection ETF (CPSM): Debuted recently, aims to match S&P 500 returns up to a cap and protect against losses over a year.
- Innovator Equity Defined Protection ETF (TJUL): World's first ETF promising no losses to investors, launched last year.
- Investment Strategy: Defined-outcome ETFs invest in FLEX options with varying strike prices, using call options for exposure and put options for protection.
- Investor Considerations: While seeking downside protection, investors may forego potential upside beyond the cap; these ETFs are good options for risk-averse investors.
Trade with 70% Backtested Accuracy
Analyst Views on IWM
No data
About the author
U.S. to Eliminate Additional 25% Tariff on Indian Imports and Lower Tariffs to 18% as India Decreases Russian Oil Purchases, According to White House Official.
U.S. Tariff Changes: The U.S. will eliminate the additional 25% tariff on Indian imports and reduce tariffs to 18%.
India's Oil Purchases: The tariff reduction comes as India decreases its purchases of Russian oil.
TRUMP CALLS FOR LOWER INTEREST RATES FROM THE FED
- Trump on Fed Interest Rates: Former President Trump expressed a desire for the Federal Reserve to lower interest rates.
- Economic Implications: Lowering interest rates could stimulate economic growth but may also raise concerns about inflation.
- Political Context: Trump's comments come amid ongoing discussions about the Fed's monetary policy and its impact on the economy.
- Public Reaction: The statement has sparked varied reactions from economists and political analysts regarding its feasibility and potential consequences.
University of Michigan Consumer Sentiment Final January at 56.4, Exceeding Consensus of 54.0 and Preliminary January Estimate of 54.0, Up from Final December's 52.9
Consumer Sentiment Index: The University of Michigan's final consumer sentiment index for January is reported at 56.4, indicating a slight increase from the preliminary figure of 54.0.
Comparison to Previous Month: The final consumer sentiment index shows a decrease from December's figure of 52.9, reflecting ongoing economic concerns among consumers.
U.S. SUPREME COURT SEEMS UNLIKELY TO GRANT TRUMP'S DEMAND TO IMMEDIATELY REMOVE FEDERAL RESERVE GOVERNOR LISA COOK
Supreme Court's Likely Decision: The U.S. Supreme Court is expected to deny Donald Trump's request for the immediate firing of Federal Reserve Governor Lisa Cook.
Context of the Request: Trump's request is part of ongoing legal and political maneuvers related to his influence over federal appointments.
Regional Banking Sector Approaches a Pivotal Turning Point
Market Trends: Technology stocks, particularly in artificial intelligence and regional banking, are currently dominating market headlines, with the S&P 500 experiencing record gains driven by these sectors.
Regional Banking Sector: The regional banking sector is approaching a critical inflection point, with the S&P Regional Banking ETF consolidating just below a multi-year resistance level near $70, which could signal a potential breakout or further challenges.
Investment Strategies: Investors are advised to consider diversified approaches, such as investing in the KRE ETF, which tracks regional banks, to mitigate risks associated with single-stock investments.
Future Outlook: The performance of regional banks could influence broader market sentiment, with a breakout above resistance potentially indicating improved credit conditions and economic resilience, while repeated failures could heighten risks of a downturn.
IBRX Stock Gains Retail Enthusiasm Following Saudi FDA Approval of Company's Bladder Cancer Immunotherapy
Expansion Plans: Immunity Bio plans to establish a regional office in Saudi Arabia to support its expansion across the Middle East and North Africa, partnering with local pharmaceutical firm Bio Pharma Cigalah.
Clinical Study Update: Enrollment for the QUILT-2005 study evaluating ANKTIVA in early-stage bladder cancer is expected to be completed by Q2 2026, with potential biological license application by the end of the year.
Stock Performance: Immunity Bio's stock surged 8% following the approval of ANKTIVA by the Saudi Food and Drug Authority, marking a significant regulatory milestone alongside existing authorizations in the US, UK, and EU.
Market Sentiment: Retail sentiment around Immunity Bio remains extremely bullish, with speculation that the approval could double the company's product revenue, reflecting a positive outlook among investors.
U.S. to Eliminate Additional 25% Tariff on Indian Imports and Lower Tariffs to 18% as India Decreases Russian Oil Purchases, According to White House Official.
U.S. Tariff Changes: The U.S. will eliminate the additional 25% tariff on Indian imports and reduce tariffs to 18%.
India's Oil Purchases: The tariff reduction comes as India decreases its purchases of Russian oil.
TRUMP CALLS FOR LOWER INTEREST RATES FROM THE FED
- Trump on Fed Interest Rates: Former President Trump expressed a desire for the Federal Reserve to lower interest rates.
- Economic Implications: Lowering interest rates could stimulate economic growth but may also raise concerns about inflation.
- Political Context: Trump's comments come amid ongoing discussions about the Fed's monetary policy and its impact on the economy.
- Public Reaction: The statement has sparked varied reactions from economists and political analysts regarding its feasibility and potential consequences.
University of Michigan Consumer Sentiment Final January at 56.4, Exceeding Consensus of 54.0 and Preliminary January Estimate of 54.0, Up from Final December's 52.9
Consumer Sentiment Index: The University of Michigan's final consumer sentiment index for January is reported at 56.4, indicating a slight increase from the preliminary figure of 54.0.
Comparison to Previous Month: The final consumer sentiment index shows a decrease from December's figure of 52.9, reflecting ongoing economic concerns among consumers.
U.S. SUPREME COURT SEEMS UNLIKELY TO GRANT TRUMP'S DEMAND TO IMMEDIATELY REMOVE FEDERAL RESERVE GOVERNOR LISA COOK
Supreme Court's Likely Decision: The U.S. Supreme Court is expected to deny Donald Trump's request for the immediate firing of Federal Reserve Governor Lisa Cook.
Context of the Request: Trump's request is part of ongoing legal and political maneuvers related to his influence over federal appointments.
Regional Banking Sector Approaches a Pivotal Turning Point
Market Trends: Technology stocks, particularly in artificial intelligence and regional banking, are currently dominating market headlines, with the S&P 500 experiencing record gains driven by these sectors.
Regional Banking Sector: The regional banking sector is approaching a critical inflection point, with the S&P Regional Banking ETF consolidating just below a multi-year resistance level near $70, which could signal a potential breakout or further challenges.
Investment Strategies: Investors are advised to consider diversified approaches, such as investing in the KRE ETF, which tracks regional banks, to mitigate risks associated with single-stock investments.
Future Outlook: The performance of regional banks could influence broader market sentiment, with a breakout above resistance potentially indicating improved credit conditions and economic resilience, while repeated failures could heighten risks of a downturn.
IBRX Stock Gains Retail Enthusiasm Following Saudi FDA Approval of Company's Bladder Cancer Immunotherapy
Expansion Plans: Immunity Bio plans to establish a regional office in Saudi Arabia to support its expansion across the Middle East and North Africa, partnering with local pharmaceutical firm Bio Pharma Cigalah.
Clinical Study Update: Enrollment for the QUILT-2005 study evaluating ANKTIVA in early-stage bladder cancer is expected to be completed by Q2 2026, with potential biological license application by the end of the year.
Stock Performance: Immunity Bio's stock surged 8% following the approval of ANKTIVA by the Saudi Food and Drug Authority, marking a significant regulatory milestone alongside existing authorizations in the US, UK, and EU.
Market Sentiment: Retail sentiment around Immunity Bio remains extremely bullish, with speculation that the approval could double the company's product revenue, reflecting a positive outlook among investors.
